Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations

Irene L. Andrulis, Hoda Anton-Culver, Jeanne Beck, Betsy Bove, Jeff Boyd, Saundra Buys, Andrew K. Godwin, John L. Hopper, Frederick Li, Susan L. Neuhausen, Hilmi Ozcelik, David Peel, Regina M. Santella, Melissa C. Southey, Nathalie J. Van Orsouw, Deon J. Venter, Jan Vijg, Alice S. Whittemore

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

A number of methods are used for mutational analysis of BRCA1, a large multi-exon gene. A comparison was made of five methods to detect mutations generating premature stop codons that are predicted to result in synthesis of a truncated protein in BRCA1. These included four DNA-based methods: two-dimensional gene scanning (TDGS), denaturing high performance liquid chromatography (DHPLC), enzymatic mutation detection (EMD), and single strand conformation polymorphism analysis (SSCP) and an RNA/DNA-based protein truncation test (PTT) with and without complementary 5′ sequencing. DNA and RNA samples isolated from 21 coded lymphoblastoid cell line samples were tested. These specimens had previously been analyzed by direct automated DNA sequencing, considered to be the optimum method for mutation detection. The set of 21 cell lines included 14 samples with 13 unique frameshift or nonsense mutations, three samples with two unique splice site mutations, and four samples without deleterious mutations. The present study focused on the detection of protein-truncating mutations, those that have been reported most often to be disease-causing alterations that segregate with cancer in families. PTT with complementary 5′ sequencing correctly identified all 15 deleterious mutations. Not surprisingly, the DNA-based techniques did not detect a deletion of exon 22. EMD and DHPLC identified all of the mutations with the exception of the exon 22 deletion. Two mutations were initially missed by TDGS, but could be detected after slight changes in the test design, and five truncating mutations were missed by SSCP. It will continue to be important to use complementary methods for mutational analysis.

Original languageEnglish (US)
Pages (from-to)65-73
Number of pages9
JournalHuman Mutation
Volume20
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

RNA
Mutation
DNA
Exons
Nonsense Codon
BRCA1 Protein
High Pressure Liquid Chromatography
Genes
Cell Line
Frameshift Mutation
Proteins
DNA Sequence Analysis
Neoplasms

Keywords

  • BRCA1
  • DHPLC
  • EMD
  • Enzymatic mutation detection
  • Molecular testing
  • Protein truncation test
  • PTT
  • Single strand conformation polymorphism analysis
  • SSCP
  • TDGS
  • Two-dimensional gene scanning

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Andrulis, I. L., Anton-Culver, H., Beck, J., Bove, B., Boyd, J., Buys, S., ... Whittemore, A. S. (2002). Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Human Mutation, 20(1), 65-73. https://doi.org/10.1002/humu.10097

Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. / Andrulis, Irene L.; Anton-Culver, Hoda; Beck, Jeanne; Bove, Betsy; Boyd, Jeff; Buys, Saundra; Godwin, Andrew K.; Hopper, John L.; Li, Frederick; Neuhausen, Susan L.; Ozcelik, Hilmi; Peel, David; Santella, Regina M.; Southey, Melissa C.; Van Orsouw, Nathalie J.; Venter, Deon J.; Vijg, Jan; Whittemore, Alice S.

In: Human Mutation, Vol. 20, No. 1, 2002, p. 65-73.

Research output: Contribution to journalArticle

Andrulis, IL, Anton-Culver, H, Beck, J, Bove, B, Boyd, J, Buys, S, Godwin, AK, Hopper, JL, Li, F, Neuhausen, SL, Ozcelik, H, Peel, D, Santella, RM, Southey, MC, Van Orsouw, NJ, Venter, DJ, Vijg, J & Whittemore, AS 2002, 'Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations', Human Mutation, vol. 20, no. 1, pp. 65-73. https://doi.org/10.1002/humu.10097
Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S et al. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Human Mutation. 2002;20(1):65-73. https://doi.org/10.1002/humu.10097
Andrulis, Irene L. ; Anton-Culver, Hoda ; Beck, Jeanne ; Bove, Betsy ; Boyd, Jeff ; Buys, Saundra ; Godwin, Andrew K. ; Hopper, John L. ; Li, Frederick ; Neuhausen, Susan L. ; Ozcelik, Hilmi ; Peel, David ; Santella, Regina M. ; Southey, Melissa C. ; Van Orsouw, Nathalie J. ; Venter, Deon J. ; Vijg, Jan ; Whittemore, Alice S. / Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. In: Human Mutation. 2002 ; Vol. 20, No. 1. pp. 65-73.
@article{462085a19a304d1f852145a3694d5c4f,
title = "Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations",
abstract = "A number of methods are used for mutational analysis of BRCA1, a large multi-exon gene. A comparison was made of five methods to detect mutations generating premature stop codons that are predicted to result in synthesis of a truncated protein in BRCA1. These included four DNA-based methods: two-dimensional gene scanning (TDGS), denaturing high performance liquid chromatography (DHPLC), enzymatic mutation detection (EMD), and single strand conformation polymorphism analysis (SSCP) and an RNA/DNA-based protein truncation test (PTT) with and without complementary 5′ sequencing. DNA and RNA samples isolated from 21 coded lymphoblastoid cell line samples were tested. These specimens had previously been analyzed by direct automated DNA sequencing, considered to be the optimum method for mutation detection. The set of 21 cell lines included 14 samples with 13 unique frameshift or nonsense mutations, three samples with two unique splice site mutations, and four samples without deleterious mutations. The present study focused on the detection of protein-truncating mutations, those that have been reported most often to be disease-causing alterations that segregate with cancer in families. PTT with complementary 5′ sequencing correctly identified all 15 deleterious mutations. Not surprisingly, the DNA-based techniques did not detect a deletion of exon 22. EMD and DHPLC identified all of the mutations with the exception of the exon 22 deletion. Two mutations were initially missed by TDGS, but could be detected after slight changes in the test design, and five truncating mutations were missed by SSCP. It will continue to be important to use complementary methods for mutational analysis.",
keywords = "BRCA1, DHPLC, EMD, Enzymatic mutation detection, Molecular testing, Protein truncation test, PTT, Single strand conformation polymorphism analysis, SSCP, TDGS, Two-dimensional gene scanning",
author = "Andrulis, {Irene L.} and Hoda Anton-Culver and Jeanne Beck and Betsy Bove and Jeff Boyd and Saundra Buys and Godwin, {Andrew K.} and Hopper, {John L.} and Frederick Li and Neuhausen, {Susan L.} and Hilmi Ozcelik and David Peel and Santella, {Regina M.} and Southey, {Melissa C.} and {Van Orsouw}, {Nathalie J.} and Venter, {Deon J.} and Jan Vijg and Whittemore, {Alice S.}",
year = "2002",
doi = "10.1002/humu.10097",
language = "English (US)",
volume = "20",
pages = "65--73",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations

AU - Andrulis, Irene L.

AU - Anton-Culver, Hoda

AU - Beck, Jeanne

AU - Bove, Betsy

AU - Boyd, Jeff

AU - Buys, Saundra

AU - Godwin, Andrew K.

AU - Hopper, John L.

AU - Li, Frederick

AU - Neuhausen, Susan L.

AU - Ozcelik, Hilmi

AU - Peel, David

AU - Santella, Regina M.

AU - Southey, Melissa C.

AU - Van Orsouw, Nathalie J.

AU - Venter, Deon J.

AU - Vijg, Jan

AU - Whittemore, Alice S.

PY - 2002

Y1 - 2002

N2 - A number of methods are used for mutational analysis of BRCA1, a large multi-exon gene. A comparison was made of five methods to detect mutations generating premature stop codons that are predicted to result in synthesis of a truncated protein in BRCA1. These included four DNA-based methods: two-dimensional gene scanning (TDGS), denaturing high performance liquid chromatography (DHPLC), enzymatic mutation detection (EMD), and single strand conformation polymorphism analysis (SSCP) and an RNA/DNA-based protein truncation test (PTT) with and without complementary 5′ sequencing. DNA and RNA samples isolated from 21 coded lymphoblastoid cell line samples were tested. These specimens had previously been analyzed by direct automated DNA sequencing, considered to be the optimum method for mutation detection. The set of 21 cell lines included 14 samples with 13 unique frameshift or nonsense mutations, three samples with two unique splice site mutations, and four samples without deleterious mutations. The present study focused on the detection of protein-truncating mutations, those that have been reported most often to be disease-causing alterations that segregate with cancer in families. PTT with complementary 5′ sequencing correctly identified all 15 deleterious mutations. Not surprisingly, the DNA-based techniques did not detect a deletion of exon 22. EMD and DHPLC identified all of the mutations with the exception of the exon 22 deletion. Two mutations were initially missed by TDGS, but could be detected after slight changes in the test design, and five truncating mutations were missed by SSCP. It will continue to be important to use complementary methods for mutational analysis.

AB - A number of methods are used for mutational analysis of BRCA1, a large multi-exon gene. A comparison was made of five methods to detect mutations generating premature stop codons that are predicted to result in synthesis of a truncated protein in BRCA1. These included four DNA-based methods: two-dimensional gene scanning (TDGS), denaturing high performance liquid chromatography (DHPLC), enzymatic mutation detection (EMD), and single strand conformation polymorphism analysis (SSCP) and an RNA/DNA-based protein truncation test (PTT) with and without complementary 5′ sequencing. DNA and RNA samples isolated from 21 coded lymphoblastoid cell line samples were tested. These specimens had previously been analyzed by direct automated DNA sequencing, considered to be the optimum method for mutation detection. The set of 21 cell lines included 14 samples with 13 unique frameshift or nonsense mutations, three samples with two unique splice site mutations, and four samples without deleterious mutations. The present study focused on the detection of protein-truncating mutations, those that have been reported most often to be disease-causing alterations that segregate with cancer in families. PTT with complementary 5′ sequencing correctly identified all 15 deleterious mutations. Not surprisingly, the DNA-based techniques did not detect a deletion of exon 22. EMD and DHPLC identified all of the mutations with the exception of the exon 22 deletion. Two mutations were initially missed by TDGS, but could be detected after slight changes in the test design, and five truncating mutations were missed by SSCP. It will continue to be important to use complementary methods for mutational analysis.

KW - BRCA1

KW - DHPLC

KW - EMD

KW - Enzymatic mutation detection

KW - Molecular testing

KW - Protein truncation test

KW - PTT

KW - Single strand conformation polymorphism analysis

KW - SSCP

KW - TDGS

KW - Two-dimensional gene scanning

UR - http://www.scopus.com/inward/record.url?scp=18444394315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18444394315&partnerID=8YFLogxK

U2 - 10.1002/humu.10097

DO - 10.1002/humu.10097

M3 - Article

VL - 20

SP - 65

EP - 73

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 1

ER -